T he development of new safe and effective rotavirus vaccines is a significant advancement for the prevention of morbidity and mortality associated with childhood gastroenteritis.
1,2 Prevention of rotavirus gastroenteritis is a priority for developing countries according to the World Health Organization and the Global Initiative for Vaccines and Immunization. 3, 4 The most current estimates suggest that this disease is associated with 400,000 to 660,000 deaths every year concentrated in the poorest countries of the world, mainly in Africa and Asia. 5 Most countries in Latin America have improved their level of development during the past decades, improvement paralleled by a decrease in gastroenteritis-associated mortality. For rotavirus, the most recent estimate is that 17.000 children die per year, mainly in the low-income countries or in poor areas of the middle-income countries. 6 For a number of middle-income countries, with a Gross Domestic Product purchasing power capacity per capita of more than U.S. $6000 such as Argentina, Brazil, Colombia, Costa Rica, Chile, Dominican Republic, Mexico, Panama, Trinidad and Tobago, 7 rotavirus-associated deaths are uncommon and the burden of disease is associated mainly with the need for hospitalization and medical care. Depending on the severity of the disease and the availability of medical care, this burden may be reflected in the need for an outpatient medical visit, an emergency room visit and/or a hospitalization that may be transient or prolonged.
In Chile, one of the rapidly developing countries of Latin America, a prospective study allowed estimation of the impact of rotavirus disease as a cause of emergency room visits and hospitalizations. 8 According to that study, rotavirus caused 34% and 47% of diarrhea-associated emergency room visits and hospitalizations among children less than 3 years of age that led to an estimation of a total of 58,000 emergency room visits and 8000 hospitalizations occurring every year for this age group throughout the country. 8 According to those estimations, one of 16 children Յ3 years requires an emergency room visit and one of 105 a hospitalization every year for rotavirus illness. Missing in this analysis is the impact of rotavirus as a cause of medical outpatient visits. In this setting, where children most probably will have mild or at most moderately severe gastroenteritis, rotavirus seems to be proportionally less common than more severe cases requiring emergency visits or hospitalizations. 9 Several studies have attempted to quantify rotavirus positivity rates among outpatient children with gastroenteritis with figures ranging from 4% to 30% in different regions. 10 -14 These large variations most likely reflect methodologic differences, mainly 15 In these clinics, assigned health personnel report on a monthly basis the number of cases of acute diarrhea defined as 3 or more loose stools in a 24-hour period with or without dehydration among children younger than 5 years of age to the Epidemiology Surveillance Unit based in Santiago, the capital city. For each of these centers, the population of children Ͻ5 years of age that seek medical attention has been established allowing the calculation of incidence rates. For 2004, this surveillance system reported an overall annual incidence rate of acute diarrhea as a cause of outpatient visits of 8% for children Ͻ5 years of age and of 11% for children Ͻ1 year of age. 15 Rotavirus-Based Outpatient Clinic Surveillance. A collaborative protocol was established between the Department of Epidemiology of the Chilean Health Ministry and the Microbiology Program of the Institute of Biomedical Sciences, Faculty of Medicine, University of Chile. Thirteen of the 32 outpatient clinics distributed from north to south of mainland Chile were initially selected for rotavirus detection based on their regularity in reporting diarrhea cases during the previous years. In these clinics, the epidemiologist of the healthcare area and clinic personnel were responsible for the weekly reporting of all acute diarrhea cases consultations in children Ͻ5 years of age and for the collection of a stool sample in the first 5 children consulting for acute diarrhea per week. For stool collection, a case of acute diarrhea was defined as 3 or more liquid stools in the previous 24 hours and not lasting for more than 3 days. The epidemiologists of the areas compromising all the selected outpatient clinics met with the study team for a 1-day meeting to discuss the protocol, assure homogeneity and determine requirements for its implementation.
Stool Sample Collection and Processing. After parental informed consent was obtained, clinic personnel obtained a stool sample from direct emission or recent emission from the diaper (less then 1 hour) if available or, if not available, made one attempt by gently introducing a thin rubber rectal tube; stool samples were stored at 4°C or Ϫ20°C if planned to be tested before or after 5 days, respectively. Stools were transported in plastic vials in Styrofoam boxes with ice packs to the Microbiology Program not surpassing a 24-hour transport period. Rotavirus was detected by enzyme-linked immunosorbent assay (IDEIA Rotavirus; DakoCytomation Ltd., Angel Drove, U.K.) as recommended by the manufacturer. Rotavirus-positive stools for which enough quantity was available for serotyping were typed for G1-G4 by a monoclonal antibody-based enzyme-linked immunosorbent assay and/or reverse transcriptase-polymerase chain reaction as previously described. 16 Stools were not tested for other pathogens. Data Analysis. For the 11 sentinel outpatient clinics, all diarrhea cases occurring in children Ͻ5 years of age were recorded and information was sent on a weekly basis to the Epidemiology Department of the Health Ministry. For children who submitted a stool sample, information on gender, age and date of stool sample was recorded in an ad hoc spreadsheet and sent on a weekly basis to the microbiology laboratory. In this prospective descriptive study, the proportion of rotavirus-positive samples by month, center and age groups was calculated including the 95% confidence limits (CLs). Relative risks and the 2 test were used to compare proportions.
RESULTS
Eleven clinics from 6 regions completed the 15-month surveillance period and were included in this study ( Fig. 1 ; Table 1 ). Two of the 13 initially selected clinics were irregular in sample collection and were thus excluded from the study. A total of 5217 acute diarrhea episodes requiring an outpatient medical visit for a total assigned population of 41,927 children Ͻ5 years of age were reported from August 1, 2004, to October 30, 2005, in the 11 clinics. Incidence rates of acute diarrhea outpatient visits for the 15-month study period ranged among the different centers from 6% to 32% (mean: 12.4%; 95% CL, 12.1-12.8%; Table 1 ). Stool samples were collected from 25% of the diarrhea episodes, ranging from 12% to 51% among the clinics. A total of 179 rotaviruspositive samples were detected from 1313 stools collected for an overall positivity of 13. 6% (95% CL, 11.8 -15.6%). Positivity rates ranged from 10% to 21% (median: 12%) among the clinics.
Rotavirus-positive outpatient visits occurred during all 15 months without a clear seasonal predominance (Fig. 2) . The median monthly positivity rate was 12% ranging from 5% to 37%. During the peak summer months (JanuaryFebruary), a higher number of stool samples was collected for rotavirus testing as expected as a result of the characteristic increase of diarrhea cases during the period (data not shown). The relative proportion of rotavirus cases was slightly less than the mean (9% and 11%, respectively) during these months, but the absolute number of cases was higher than in all other months. The lowest absolute numbers of overall diarrhea and rotavirus diarrhea cases occurred during the 2 colder months (June-July Most stool samples were from children younger than 3 years of age (1086 of 1313 ͓83%͔) as were most rotaviruspositive samples (160 of 179 ͓89%͔). Positivity rates and total numbers of rotavirus cases were highest among children between 6 months and 2 years of age (15%) compared with the other ages (9%) with a relative risk of 1.64 (95% CI, 1.13-2.36) (Fig. 2) .
Serotyping was done in 107 of 179 (60%) rotaviruspositive samples. In order of frequency, serotype G4 (67%) followed by G1 (18%), non-G1-G4 (10%) and G3 (5%) were identified. G4 was the predominant type throughout the 15 months and in all but one outpatient clinic.
DISCUSSION
During a 15-month prospective surveillance in 11 outpatient clinics from north to south of mainland Chile, rotavirus was identified in approximately 14% of all diarrheaassociated outpatient medical visits occurring in 1313 children younger than 5 years of age. This finding is comparable to that reported in other regions, eg, 12% in Malaysia and 18% in Japan, where children requiring an outpatient consult were studied. 10, 12 When children with more severe episodes are included in these surveillances such as those requiring an emergency room visit or hospitalization, the rotavirus proportion increases reaching proportions closer to 30% to 50% or higher. 8, 11, 14 The results of this study allow further discrimination of the burden of rotavirus disease in Chile that can probably be extrapolated to other regions with a similar socioeconomic and healthcare reality. We had previously reported that in Chile for children less than 3 years of age, rotavirus is associated with almost 50% of gastroenteritis-associated hospitalizations and 34% of emergency room visits 8 ; in this study for this same age group of children, rotavirus was detected in 14.7% of gastroenteritis-associated A simple rule of thumb that can be extracted from these results is that for children younger than 3 years of age with acute diarrhea, rotavirus is associated with approximately 1:2 hospitalizations, 1:3 emergency room visits and 1:6 -7 outpatient medical visits. The mean incidence rate of medical visits for acute diarrhea in the 11 clinics during the 15-month period was 12.4% (95% CL, 12.1-12.8%). Extrapolating these results nationwide with a population estimate of 1,230,000 children younger than 5 years of age for the period 2004 to 2005, 17 a total of 152,520 (range: 148,830 -157,414) outpatient medical visits for acute gastroenteritis can be estimated for the period. Considering the mean and 95% CL of diarrhea visits and rotavirus positivity, this virus would have been responsible for 20,739 medical visits (range: 17,558 -24,556) during the 15-month period. Thus, to our previous estimate of 8000 hospitalizations and 53,000 emergency room visits every year for children Յ3 years of age, 8 an additional 11,658 to 16,305 outpatient medical visits (as calculated for a 12-month period for this age group) need to be added. The results from this study are in a similar range with those from other regions that report medical visits to be twice as common as hospitalizations 18 reaching up to 5 to 6 times 19 ; our estimates are closer to 8 to 9 times after adding both emergency room and outpatient consults.
Rotavirus was detected year round throughout Chile in this study as previously shown for the metropolitan region. 8 Positivity rates ranged from 5% to 22%, but no consistent pattern could be detected for the different seasons. The expected increase in summer diarrhea was paralleled by a relative increase in rotavirus cases that sustained a positivity rate close to the mean; thus, rotavirus clearly circulates during the summer in Chile. The decrease in diarrhea cases during the winter is a common observation, in part because medical care is overwhelmed by respiratory infections. Because this study was extended to a 15-month period, we were able to compare a 3-month period (August-October) for 2 years. The second period had a significantly higher rotavirus positivity rate in a scenario of fewer overall diarrhea cases. A "more intense" rotavirus year in one or more regions might explain this situation, but this hypothesis would require more stringent surveillance conditions to discard possible stool collection bias during the second year as discussed subsequently. The majority of rotavirus-associated ambulatory consultations occurred between the ages of 6 months and 2 years of age with positivity rates declining after and before this age group. This pattern of consultation is consistent with the peak ages of symptomatic rotavirus infection detected by cohort studies and surveillance of hospitalized or emergency room cases and similar to the age pattern reported for ambulatory consults in other areas such as Japan. 8, 12, 20, 21 Serotype G4 largely predominated throughout 2004 to 2005 followed by G1 in all regions representing a shift from the G1 predominance observed during previous years. 16 The low circulation of G2 previously reported for the metropolitan region was now shown for the entire country during this surveillance period; although G9 was not studied, the small number of nontypable samples suggests that it is not yet predominant in Chile.
This study has limitations that need to be considered before establishing definite conclusions. Reporting and collection of stool samples relied on local personnel in each of the 11 clinics. Although a centralized meeting of coordination and establishment of uniform criteria for the notification of diarrhea cases and collection of stool samples was undertaken with the area epidemiologists, biases in both notification and stool selection might have occurred among collaborating personnel in one or more clinics. This could explain in part the large differences in acute diarrhea incidence rates and the proportion of rotavirus positivity among the different clinics. Repeated phone contacts with the area epidemiologists who periodically visited the clinics did not clearly identify potential biases. Considering the complexity of prospective multicenter surveillance studies such as this one in which the cooperation of physicians, nurses and other personnel is required, we believe that the collection of stool samples from 25% of the diarrhea episodes reported, with a relatively uniform rotavirus positivity rate, is adequate and sufficient to support the overall estimates presented here. We believe that the overall burden of rotavirus infections in rapidly developing countries requires thorough evaluation of hospitalizations, emergency room and outpatient clinic visits. Cost-benefit analysis for the decision-making surrounding incorporation of new rotavirus vaccines to national programs will need to consider the full spectrum of healthcare resources required to treat otherwise preventable acute diarrhea cases.
